Johnson & Johnson vs. Minerva Neurosciences, Inc
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| JNJ | NERV | |
|---|---|---|
| Market Cap | $609.54 billion | $158.52 million |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | NERV | |
|---|---|---|
| Dividend Yield | 2.12% | — |
JNJ and NERV split the dividend factors evenly.
Risk & Sentiment
| JNJ | NERV | |
|---|---|---|
| Short Interest | 0.67% | 3.52% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, NERV overview, NERV financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.